RETREATMENT OF HCV DAA FAILURES: HCV INFECTION MAY BE INCURABLE

被引：4
|
作者：
Hezode, C. [1 ]
Fourati, S. [2 ]
Scoazec, G. [1 ]
Soulier, A. [2 ]
Varaut, A. [1 ]
Francois, M. [1 ]
Ruiz, I. [2 ]
Mallat, A. [1 ]
Chevaliez, S. [2 ]
Pawlotsky., J. -M. [2 ]
机构：
[1] Hop Henri Mondor, Hepatol, Creteil, France
[2] Hop Henri Mondor, Virol, Creteil, France
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00630-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-217
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [21] Behaviour of sustained responders to anti-HCV treatment: May HCV infection be eradicated?
    Petrarca, A
    Arena, U
    Giannini, C
    Monti, M
    Solazzo, V
    Giannelli, F
    Caini, P
    La Villa, G
    Laffi, G
    Zignego, AL
    HEPATOLOGY, 2005, 42 (04) : 653A - 654A
  • [22] Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients
    Gomez-Ayerbe, C.
    Palacios, R.
    Perez, C.
    Tellez, F.
    Sayago, C.
    Rios, M. J.
    Martin-Aspas, A.
    Camacho, A.
    Munoz, L.
    Santos, J.
    HIV MEDICINE, 2019, 20 : 298 - 298
  • [23] Impact of DAA Treatment on Cardiovascular Disease Risk in Chronic HCV Infection: An Update
    Roguljic, Hrvoje
    Nincevic, Vjera
    Bojanic, Kristina
    Kuna, Lucija
    Smolic, Robert
    Vcev, Aleksandar
    Primorac, Dragan
    Vceva, Andrijana
    Wu, George Y.
    Smolic, Martina
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [24] Treatment of acute HCV infection with direct acting antivirals (DAA) in HIV patients
    Gomez-Ayerbe, C.
    Palacios, R.
    Tellez, F.
    Sayago, C.
    Rios, M.
    Martin-Aspas, A.
    Camacho, A.
    Munoz, L.
    Santos, J.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [25] RESTORATION OF HCV-SPECIFIC T CELLS FOLLOWING DAA THERAPY IN ACUTE HCV INFECTION-SUPPORT FOR TREATMENT OF ACUTE INFECTION.
    Casey, Julia
    MacParland, Sonya
    Zahoor, Atif
    Janssen, Harry L. A.
    Matthews, Gail
    Marks, Pip
    Grebely, Jason
    Dore, Gregory
    Hansen, Bettina E.
    Kaul, Rupert
    Chua, Conan
    Gehring, Adam J.
    Feld, Jordan J.
    HEPATOLOGY, 2020, 72 : 613A - 614A
  • [26] The clinical outcome and safety of generic DAA treatment for HCV infection in Vietnam in 2016
    Vu, H. T. T.
    Ishizaki, A.
    Nguyen, Q. T.
    Nguyen, H. N.
    Le, H. T.
    Nguyen, T. V.
    Nguyen, K. V.
    Ichimura, H.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 61 - 62
  • [27] The challenge of HCV-retreatment after DAA-failure: real-life experience advocates for caution
    Cento, V.
    Barbaliscia, S.
    Di Maio, V. C.
    Masetti, C.
    Minichini, C.
    Magni, C. F.
    Micheli, V.
    Marenco, S.
    Nicolini, L. A.
    Bruzzone, B.
    Troshina, Y.
    Baiguera, C.
    Dentone, C.
    Calvaruso, V.
    Paolucci, S.
    Melis, M.
    Aragri, M.
    Bertoli, A.
    Lenci, I.
    Landonio, S.
    Schiavini, M.
    Sticchi, L.
    Ruggiero, T.
    Polilli, E.
    Messina, V.
    Pellicelli, A.
    Boglione, L.
    Cozzolongo, R.
    Biolato, M.
    Morisco, F.
    Siciliano, M.
    Parruti, G.
    Barbarini, G.
    Craxi, A.
    Babudieri, S.
    Puoti, M.
    Ciancio, A.
    Rizzardini, G.
    Coppola, N.
    Angelico, M.
    Perno, C. F.
    Ceccherini-Silberstein, F.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S744 - S745
  • [28] Hcv genotypes and pediatric HCV infection
    Bortolotti, F
    Resti, M
    Verucchi, G
    Nebbia, G
    Giacchino, R
    Marazzi, MG
    Marcellini, M
    Barbera, C
    Maggiore, G
    Bartolacci, S
    Guido, M
    JOURNAL OF HEPATOLOGY, 2004, 40 : 137 - 137
  • [29] Effectiveness of pangenotypic retreatment of HCV infection after prior failure of pangenotypic therapies
    Flisiak, Robert
    Janocha-Litwin, Justyna
    Parfieniuk-Kowerda, Anna
    Zarebska-Michaluk, Dorota
    Sitko, Marek
    Anna, Piekarska
    Bialkowska, Jolanta
    Dybowska, Dorota
    Dobracki, Witold
    Krzysztof, Simon
    Murawska-Ochab, Aleksandra
    Pawlowska, Malgorzata
    JOURNAL OF HEPATOLOGY, 2022, 77 : S592 - S593
  • [30] HCV/HIV coinfection in the DAA era: which patients have not been treated for HCV?
    Rodriguez-Monaco, F. D.
    Schwarze-Zander, C.
    Wasmuth, J-C
    Rockstroh, J. K.
    Boesecke, C.
    HIV MEDICINE, 2019, 20 : 291 - 291
12345